| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy61 | Chief Financial Officer | Sell | 1,033 | $25.13 | $25,959.29 | -0.7% | -19.6% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Thomas Paul | Director | Sell | 21,399 | $29.61 | $633,709.99 | -61.3% | -4.3% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +17.6% | -9.6% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Berard Todd68 | Chief Marketing Officer | Sell | 358 | $25.13 | $8,996.54 | -0.3% | -19.6% | - | |
| Dec 9, 2025 | ENOV Enovis Corp | Pryor Daniel A74 | Former EVP, Strategy &Bus Dev | Sell | 1,665 | $27.21 | $45,297.99 | -1.0% | -8.8% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 18,000 | $0.00 | - | +50.1% | -9.6% | - | |
| Dec 9, 2025 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,700 | $84.47 | $650,412.07 | -16.2% | +1.2% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Began Marc A | EVP &General Counsel | Sell | 9,278 | $31.21 | $289,547.82 | -22.7% | -4.3% | - | |
| Dec 9, 2025 | IRMD Iradimed Corp | Hawkins James B59 | - | Sell | 3,000 | $96.61 | $289,837.50 | -9.5% | +3.6% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.69 | EVP &Chief Scientific Officer | Sell | 631 | $25.13 | $15,857.03 | -0.2% | -19.6% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 61,463 | $31.21 | $1,918,137.30 | -41.0% | -4.3% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 519 | $25.13 | $13,042.47 | -0.3% | -19.6% | - | |
| Dec 9, 2025 | CBLL Ceribell, Inc. | Burke William W75 | Director | Sell | 32,728 | $22.02 | $720,670.56 | -48.5% | -13.9% | - | |
| Dec 9, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 5,232 | $3.04 | $15,905.28 | -1.9% | -37.1% | - | |
| Dec 9, 2025 | NSPR Inspiremd, Inc. | Stuka Paul | Director | Buy | 5,073 | $1.81 | $9,182.13 | +1.3% | -8.8% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Pritzker Jennifer N.49 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Johnson John49 | Director | Sell | 45,379 | $30.64 | $1,390,392.87 | -53.5% | -4.3% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Pelizzon David R56 | Director, 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | BFLY Butterfly Network, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Sell | 945,397 | $3.24 | $3,064,544.25 | -70.4% | +21.3% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Squadron Capital Holdings LLC63 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 9, 2025 | ATEC Alphatec Holdings, Inc. | Squadron Capital LLC63 | 10% Owner | Sell | 250,000 | $21.18 | $5,295,098.22 | -1.2% | -37.7% | - | |
| Dec 8, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 988 | $21.45 | $21,192.60 | -0.2% | -38.6% | - | |
| Dec 8, 2025 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 20,000 | $19.33 | $386,594.00 | -14.2% | -26.1% | - | |
| Dec 8, 2025 | RMD Resmed Inc | Farrell Michael J.62 | Chairman And CEO | Sell | 4,991 | $251.41 | $1,254,795.79 | -1.1% | +1.2% | - | |
| Dec 8, 2025 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 5,000 | $95.43 | $477,163.36 | - | +5.0% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.